Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

We focus on deadly forms of lymphoma and specific areas of interest include: (1) the biology of immune receptors that control lymphoma growth and shape the microenvironment; (2) oncogenic RNA ...

Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...

Lymphoma is a blood cancer that begins when ... are removed and treated in the lab to produce chimeric antigen receptors, or ...

SGN-CD19A demonstrated anti-tumor activity across a panel of cell lines derived from multiple B-cell lymphoma and leukemia subtypes. [53] MDX-1206, which also targets CD19, is conjugated to the ...

To test this hypothesis, an early-phase trial (NCT01976585) in low-grade lymphoma was carried out testing a unique in situ vaccine (ISV) combining: 1) fms-like tyrosine kinase 3 ligand (FLT3L) to ...

The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect ...

lymphoma and other blood and bone marrow diseases. Her research aims to improve the lives of bone marrow and blood stem cell transplant recipients. She leads a nationwide research network that focuses ...